Article
GPR120, a potential therapeutic target for experimental colitis in IL-10 deficient mice.
Oncotarget - 31 Jan 2017
Zhao Jie, Wang Honggang, Shi Peiliang, Wang Wenbo, Sun Ye
Abstract excerpt
It has been proved that interleukin-10-knockout (IL-10 KO) mice display the most similar characteristics to that of human Crohn's disease (CD). Docosahexaenoic acid (DHA) has well established beneficial effects on human and animal models health with potent anti-inflammatory effects with poorly understood mechanisms. This study was aimed at figuring out whether DHA could ameliorate the Crohn's colitis by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
